Visual working memory impairment in premanifest gene-carriers and early Huntington's disease

Journal of Huntington's Disease

Volumn 1, Issue 1, 2012, Pages 97-106

  Dumas, Eve M ^a   Say, Miranda J ^b   Jones, Rebecca ^c   Labuschagne, Izelle ^d   O'Regan, Alison M ^d   Hart, Ellen P ^a   Van Den Bogaard, Simon J A ^a   Queller, Sarah ^e   Justo, Damian ^f   Coleman, Allison ^g   Dar Santos, Rachelle C ^g   Dürr, Alexandra ^f   Leavitt, Blair R ^g   Tabrizi, Sarah J ^b   Roos, Raymund A C ^a   Stout, Julie C ^d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d MONASH UNIVERSITY   (Australia)

^e Queller Consulting   (United States)

^f INSERM   (France)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

cognitive dysfunction; Huntington's disease; premanifest gene carriers; visual working memory

Indexed keywords

ADULT; CASE CONTROL STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; HUNTINGTON CHOREA; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; SHORT TERM MEMORY;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HUNTINGTON DISEASE; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 84890079064     PISSN: 18796397     EISSN: 18796400     Source Type: Journal    
DOI: 10.3233/JHD-2012-120010     Document Type: Article

References (51)

1. Tabrizi SJ, Reilmann R, Roos RAC, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, Frost C, Langbehn DR, and the TRACK-HD investigators. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol. 2012;11:42-53.
2. Stout JC, Jones R, Labuschagne I, O'Regan A, Say MJ, Dumas EM, Queller S, Justo D, dar Santos RC, Coleman A, Hart E, Dürr A, Leavitt BR, Roos RAC, Langbehn DR, Tabrizi SJ, Frost C. Evaluation of longitudinal 12- and 24-month cognitive outcomes in premanifest and early Huntington's disease. J Neurol Neurosurg Psychiatry. 2012; DOI:10.1136/jnnp-2011-301940.
3. Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt B, Jones R, Landwehrmeyer B, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn D, Reilmann R, Stout JC, and the TRACK-HD investigators. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. The Lancet Neurology. 2011;10:31-42.
4. Walker FO. Huntington's disease. Lancet. 2007;369:218-23.
5. Moses JAJ, Golden CJ, Berger PA, Wisniewski AM. Neuropsychological deficits in early, middle and late stage Huntington's disease as measured by the Luria-Nebraska Neuropsychological Battery. The International Journal of Neuroscience. 1981;14:95-100.
6. Kirkwood S, Su JL, Conneally M, Foroud T. Progression of symptoms in early and middle stages of Huntington disease. Arch Neurol. 2001;58:273-8.
7. Stout JC, Paulsen J, Queller S, Solomon AC, Whitlock KB, Campbell C, Carlozzi N, Duff K, Beglinger L, Langbehn DR, Johnson S, Biglan K, Aylward E. Neurocognitive signs in prodromal Huntington disease. Neuropsychology. 2011;25:1-14.
8. Solomon AC, Stout JC, Weaver M, Queller S, Tomusk A, Burr Whitlock K, Hui SL, Marshall J, Gray Jackson J, Siemers ER, Beristain X, Wojcieszek J, Foroud T. Ten-year rate of longitudinal change in neurocognitive and motor function in prediagnosis Huntington disease. Mov Disord. 2008;23(13):1830-6.
9. Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RAC, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, Landwehrmeyer B, Stout JC, TRACK-HD-Investigators. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: Cross-sectional analysis of baseline data. Lancet Neurol. 2009;8(9):791-801.
10. Lemiere J, Decruyenaere M, Evers-Kiebooms G, Vandenbussche E, Dom R. Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation - A longitudinal follow-up study. J Neurol. 2004;251(8):935-42.
11. Finke K, Bublak P, Dose M, Muller HJ, Schneider WX. Parameter-based assessment of spatial and non-spatial attentional deficits in Huntington's disease. Brain. 2006;129:1137-51.
12. Baddeley A. Working memory. Science. 1992;255:556-9.
13. Lawrence AD, Watkins LHA, Sahakian BJ, Hodges JR, Robbins TW. Visual object and visuospatial cognition in Huntington's disease: Implications for information processing in corticostriatal circuits. Brain. 2000;123(7):1349-64.
14. Lemiere J, Decruyenaere M, Evers-Kiebooms G, Vandenbussche E, Dom R. Longitudinal study evaluating neuropsychological changes in so-called asymptomatic carriers of the Huntington's disease mutation after 1 year. Acta Neurol Scand. 2002;106(3):131-41.
15. Davis JD, Filoteo JV, Kesner RP. Is short-term memory for discrete arm movements impaired in Huntington's disease? Cortex. 2007;43(2):255-63.
16. Bachoud-Levi AC, Maison P, Bartolomeo P, Boisse MF, Dalla Barba G, Ergis AM, Baudic S, Degos JD, Cesaro P, Peschanski M. Retest effects and cognitive decline in longitudinal followup of patients with early HD. Neurology. 2001;56(8):1052-8.
17. Verny C, Allain P, Prudean A, Malinge M, Gohier B, Scherer C, Bonneau D, Dubas F, Le Gall D. Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene. Eur J Neurol. 2007;14(12):1344-50.
18. Stout JC, Weaver M, Solomon AC, Queller S, Hui S, Johnson S, Gray J, Beristain X, Wojcieszek J, Foroud T. Are cognitive changes progressive in prediagnostic HD? Cogn Behav Neurol. 2007;20(4):212-8.
19. Lawrence AD, Hodges JR, Rosser AE, Kershaw A, ffrench-Constant C, Rubinsztein DC, Robbins TW, Sahakian BJ. Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain: A Journal of Neurology. 1998;121(7):1329-41.
20. Kirkwood SC, Siemers E, Stout JC, Hodes ME, Conneally PM, Christian JC, Foroud T. Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers. Arch Neurol. 1999;56(5):563-8.
21. Witjes-Ane M-N, Vegter-van der Vlis M, van Vugt JP, Lanser JB, Hermans J, Zwinderman A, Van Ommen G-JB, Roos RA. Cognitive and motor functioning in gene carriers for Huntington's disease: a baseline study. J Neuropsychiatry Clin Neurosci. 2003;15:7-16.
22. Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, MacDonald M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, Hayden M, The Predict HDI, Coordinators of the Huntington Study G. Detection of Huntington's disease decades before diagnosis: The Predict-HD study. J Neurol Neurosurg Psychiatry. 2008;79(8):874-80.
23. Robins Wahlin T-B, Larsson MU, Luszcz MA, Byrne GJ. WAIS-R features of preclinical Huntington's disease: implications for early detection. Dement Geriatr Cogn Disord. 2010;29:342-50.
24. Robins Wahlin T-B, Lundin A, Dear K. Early cognitive deficits in Swedish gene carriers of Huntington's disease. Neuropsychology. 2007;21(1):31-44.
25. de Boo GM, Tibben AA, Hermans JA, Jennekens-Schinkel A, Maat-Kievit A, Roos RA. Memory and learning are not impaired in presymptomatic individuals with an increased risk of Huntington's disease. J Clin Exp Neuropsychol. 1999;21:831-6.
26. Constantinidis C, Wang XJ. A neural circuit basis for spatial working memory. Neuroscientist. 2004;10:553-65.
27. Heyder K, Suchan B, Daum I. Cortico-subcortical contributions to executive control. Acta Psychol (Amst). 2004;115:271-89.
28. O'Reilly RC, Frank MJ. Making working memory work: A computational model of learning in the prefrontal cortex and basal ganglia. Neural Comput. 2006;18:283-328.
29. Aylward EH, Codori AM, Barta PE, Pearlson GD, Harris GJ, Brandt J. Basal ganglia volume and proximity to onset in presymptomatic Huntington disease. Arch Neurol. 1996;53:1293-6.
30. Montoya A, Price BH, Menear M, Lepage M. Brain imaging and cognitive dysfunctions in Huntington's disease. J Psychiatry Neurosci. 2006;31(1):21-9.
31. Bohanna I, Georgiou-Karistianis N, Hannan AJ, Egan GF. Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease. Brain Research Reviews. 2008;58(1):209-25.
32. Jurgens CK, van deWiel L, van Es ACGM, Grimbergen YM, Witjes-Ane M-N, van der Grond J, Middelkoop HAM, Roos RA. Basal ganglia volume and clinical correlates in 'preclinical' Huntington's disease. J Neurol. 2008;255:1785-91.
33. Rosas HD, Hevelone ND, Zaleta AK, Greve DN, Salat DH, Fischl B. Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology. 2005;65(5):745-7.
34. Wolf RC, Sambataro F, Vasic N, Schonfeldt-Lecuona C, Ecker D, Landwehrmeyer B. Altered frontostriatal coupling in premanifest Huntington's disease: Effects of increasing cognitive load. Eur J Neurol. 2008;15(11):1180-90.
35. Wolf RC, Sambataro F, Vasic N, Shonfeldt-Lecuona C, Ecker D, Landwehrmeyer B. Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease. Exp Neurol. 2008;213(1):137-44.
36. van der Hiele K, Jurgens CK, Vein AA, Reijntjes RHAM, Witjes-Ane M-NW, Roos RAC, van Dijk G, Middelkoop HAM. Memory activation reveals abnormal EEG in preclinical Huntington's disease. Mov Disord. 2007;22(5):690-5.
37. Aylward EH, Li Q, Stine OC, Ranen N, Sherr M, Barta PE, Bylsma FW, Pearlson GD, Ross CA. Longitudinal change in basal ganglia volume in patients with Huntington's disease. Neurology. 1997;48:392-9.
38. Paulsen JS, Magnotta VA, Mikos AE, Paulson HL, Penziner E, Andreasen NC, Nopoulos PC. Brain structure in preclinical Huntington's disease. Biol Psychiatry. 2006;59(1):57-63.
39. Van den Bogaard SJ, Dumas EM, Acharya TP, Johnson H, Langbehn DR, Scahill RI, Tabrizi SJ, van Buchem MA, Van der Grond J, Roos RA, Group T-HI. Early atrophy of pallidum and accumbens nucleus in Huntington's disease. J Neurol. 2011;258:412-20.
40. Middleton FA, Strick PL. Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Research Reviews. 2000;31(2-3):236-50.
41. Witjes-Ane M-N, Mertens B, van Vugt JP, Bachoud-Levi AC, van Ommen G-JB, Roos RA. Longitudinal evaluation of "presymptomatic" carriers of Huntington's disease. J Neuropsychiatry Clin Neurosci. 2007;19(3):310-7.
42. Huntington Study Group. Unified Huntington's Disease Rating Scale-99. Huntington Study Group. 1999.
43. Penney JBJ, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH. CAG repeat number governs the development rate of pathology in Huntington's disease. Annuals of Neurology. 1997;41:689-92.
44. Langbehn DR, Brinkman RR, Falush D, Paulsen JS, Hayden MR, Collaborative IHD. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin Genet. 2004;65(4):267-77.
45. Shoulson I, Fahn S. Huntington disease: clinical care and evaluation. Neurology. 1979;29:1-3.
46. Cowan N. The magical number 4 in short-term memory: A reconsideration of mental storage capacity. Behav Brain Sci. 2001;24(1):87-185.
47. Cowan N, Elliott EM, Saults JS, Morey CC, Mattox S, Hismjatullina A, Conway ARA. On the capacity of attention: Its estimation and its role in working memory and cognitive aptitudes. Cogn Psychol. 2005;51(1):42-100.
48. Liang KY, Zeger SL. Inference based on estimating functions in the presence of nuisance parameters. Statistical Science. 1995;10:158-73.
49. Liang KY, Zeger SL. Regression analysis for correlated data. Annu Rev Public Health. 1993;14:43-68.
50. Lange KW, Sahakian BJ, Quinn NP, Marsden CD, Robbins TW. Comparison of executive and visuospatial memory function in Huntington's Disease and dementia of Alzheimer-type matched for degree of dementia. Neurology, Neurosurgery and Pyschiatry. 1995;58(5):598-606.
51. Berg C, Hertzog C, Hunt E. Age differences in the speed of mental rotation. Dev Psychol. 1982;18:95-107.